Liminatus Pharma Files 8-K/A Amendment
Ticker: LIMNW · Form: 8-K/A · Filed: Jun 2, 2025 · CIK: 1971387
| Field | Detail |
|---|---|
| Company | Liminatus Pharma, Inc. (LIMNW) |
| Form Type | 8-K/A |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, acquisition, financials
TL;DR
Liminatus Pharma filed an 8-K/A amendment on 6/2/25 for events on 4/30/25, covering asset deals & financials. Formerly Iris Parent Holding Corp.
AI Summary
Liminatus Pharma, Inc. filed an amendment (8-K/A) on June 2, 2025, related to events as of April 30, 2025. The filing concerns the completion of an acquisition or disposition of assets and includes financial statements and exhibits. The company was formerly known as Iris Parent Holding Corp. until March 28, 2023.
Why It Matters
This amendment provides updated information regarding asset transactions and financial disclosures for Liminatus Pharma, Inc., which is crucial for investors to understand the company's current operational and financial standing.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous report and primarily contains procedural updates and financial statements, not indicating new significant risks.
Key Players & Entities
- Liminatus Pharma, Inc. (company) — Registrant
- Iris Parent Holding Corp. (company) — Former Company Name
- 20250430 (date) — Date of Report
- 20250602 (date) — Filing Date
FAQ
What is the primary purpose of this 8-K/A filing?
The primary purpose of this 8-K/A filing is to report the completion of an acquisition or disposition of assets and to include financial statements and exhibits.
What was Liminatus Pharma, Inc.'s former name?
Liminatus Pharma, Inc.'s former name was Iris Parent Holding Corp.
When did the company change its name?
The company changed its name on March 28, 2023.
What is the exact date of the report this amendment pertains to?
The date of the earliest event reported is April 30, 2025.
What is the filing date of this amendment?
This amendment was filed on June 2, 2025.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on June 2, 2025 regarding Liminatus Pharma, Inc. (LIMNW).